Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.2% | −5.2% | −5.8% | −4.4% | +24.4% | +27.8% | +85.4% | +62.0% | +158.5% | +983.0% |
| Peer average | −5.6% | −11.2% | −14.8% | −18.1% | −5.7% | −2.0% | +47.3% | +12.2% | +330.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$47 of every $1,000 in FBT is Genmab
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GMABGenmab A/S () | Healthcare | 4.67% | $466.75 | 2.7M | $136.9M |
| 2 | ADMAADMA Biologics | Healthcare | 4.34% | $433.87 | 9.5M | $127.2M |
| 3 | REGNRegeneron Pharmaceuticals | Healthcare | 4.17% | $416.74 | 132K | $122.2M |
| 4 | TGTXTG Therapeutics | Healthcare | 3.95% | $394.82 | 1.8M | $115.8M |
| 5 | ARGXargenx SE () | Healthcare | 3.85% | $384.73 | 120K | $112.8M |
| 6 | ALKSAlkermes | Healthcare | 3.83% | $383.16 | 2.4M | $112.4M |
| 7 | ONCBeOne Medicines () | Healthcare | 3.80% | $379.94 | 279K | $111.4M |
| 8 | BMRNBioMarin Pharmaceutical | Healthcare | 3.78% | $377.69 | 1.8M | $110.7M |
| 9 | GILDGilead Sciences | Healthcare | 3.71% | $371.18 | 654K | $108.8M |
| 10 | EXELExelixis | Healthcare | 3.71% | $370.55 | 1.7M | $108.7M |
| 11 | NBIXNeurocrine Biosciences | Healthcare | 3.70% | $370.42 | 694K | $108.6M |
| 12 | BIIBBiogen | Healthcare | 3.69% | $368.92 | 438K | $108.2M |
| 13 | TARSTarsus Pharmaceuticals | Healthcare | 3.58% | $357.72 | 1.4M | $104.9M |
| 14 | AMGNAmgen | Healthcare | 3.56% | $356.40 | 238K | $104.5M |
| 15 | BRKRBruker | Healthcare | 3.56% | $355.62 | 1.7M | $104.3M |
of the $341B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GMAB | Genmab A/S () | 4.67% |
| 2 | ADMA | ADMA Biologics | 4.34% |
| 3 | REGN | Regeneron Pharmaceuticals | 4.17% |
| 4 | TGTX | TG Therapeutics | 3.95% |
| 5 | ARGX | argenx SE () | 3.85% |
| 6 | ALKS | Alkermes | 3.83% |
| 7 | ONC | BeOne Medicines () | 3.80% |
| 8 | BMRN | BioMarin Pharmaceutical | 3.78% |
| 9 | GILD | Gilead Sciences | 3.71% |
| 10 | EXEL | Exelixis | 3.71% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 13, 2024 | Dec 31, 2024 | $1.17 |
| Dec 30, 2021 | Jan 10, 2022 | $2.21 |
| Sep 23, 2015 | Sep 30, 2015 | $0.0200 |
| Jun 24, 2015 | Jun 30, 2015 | $0.0650 |
| Mar 25, 2015 | Mar 31, 2015 | $0.0480 |
| Dec 23, 2014 | Dec 31, 2014 | $0.0524 |
| Jun 23, 2008 | Jun 30, 2008 | $0.27 |